Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study. [PDF]
Karsten Dafonte K +7 more
europepmc +1 more source
Low-Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire. [PDF]
Spencer H +4 more
europepmc +1 more source
Temporal changes in etiology, complications, and infection-related admissions among patients with cirrhosis: a 20-year single-center study. [PDF]
Su R, Yao W, Mian Y, Zhang Y, Yang S.
europepmc +1 more source
Open-label randomized controlled study of salt-restricted <i>vs</i> salt-unrestricted diet in patients with cirrhosis with hyponatremia. [PDF]
Marrapu S +6 more
europepmc +1 more source
Association Between Systemic Inflammation Indices and Recurrence Risk in Primary Budd-Chiari Syndrome. [PDF]
Shen Z +8 more
europepmc +1 more source
Effects of Opioids, Benzodiazepines, Gabapentinoids, and Antidepressants on Fracture Risk in Alcohol-Related Cirrhosis. [PDF]
Kraglund F +4 more
europepmc +1 more source
Standardization of the Cirrhosis Admission Process and Its Impact on Inpatient Management and Patient Outcomes. [PDF]
Lavette LE +6 more
europepmc +1 more source
Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival. [PDF]
Bienvenue I +28 more
europepmc +1 more source
Changing Etiological Patterns and Predictors of In-Hospital Mortality in Decompensated Cirrhosis: A 10-Year Cohort Study Before and After COVID-19. [PDF]
Bălăceanu LA +5 more
europepmc +1 more source
Study of Cardiovascular Dysfunction in Cirrhosis and Its Correlation With Severity at a Tertiary Care Hospital. [PDF]
Behera BK, Upadhyaya R, Das M, Behera S.
europepmc +1 more source

